Insights from 2023 ESMO Annual Meeting
Playback speed
10 seconds
ESMO 2023 Insights: "TULIP Trial - Trastuzumab Duocarmazine vs. Physician's Choice Therapy in Pre-Treated HER2+ mBC"
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Philippe Aftimos
By
Insights from 2023 ESMO Annual Meeting
FEATURING
Philippe Aftimos
286 views
November 3, 2023
Comments 0
Login to view comments.
Click here to Login
Breast